Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative...
-
Vidyard Recognized for Sales Technology Innovation in 8th Annual MarTech Breakthrough Awards Program
LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MarTech Breakthrough, a leading market intelligence organization that recognizes the most innovative companies in the global marketing, sales and...
-
Bethesda, MD, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The latest survey data from SANS Institute, the world’s most trusted provider of cybersecurity training, reveals that 80% of organizations rank social...
-
VLN® Early Adoption Commercial Activity Expands with Two Partner Brand Launches in Progress – Smoker Friendly and Pinnacle Commenced Pinnacle VLN® Stocking Shipments for Almost 1,000 Locations of...
-
Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs, supporting potential for improved protection against infection ...
-
New York City, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- In 2025, CrazyBulk is redefining building muscle after 50 by boosting healthy testosterone levels, improving mTOR responsiveness, and enhancing...
-
ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections,...
-
London, UK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PhenQ leads 2025 with a multi-action, science-informed approach to weight loss - no needles, no prescriptions, just clean, sustainable natural weight...
-
Boston, Aug. 13, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Smart Medical Devices: Global Markets” is projected to grow from $87.7 billion in 2025 to $193.3 billion...
-
TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative...